These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35841068)

  • 41. Levels of maternal serum angiogenic factors in third-trimester normal pregnancies: reference ranges, influence of maternal and pregnancy factors and fetoplacental Doppler indices.
    Lobmaier SM; Figueras F; Mercade I; Crovetto F; Peguero A; Parra-Saavedra M; Ortiz JU; Crispi F; Gratacós E
    Fetal Diagn Ther; 2014; 36(1):38-43. PubMed ID: 24903330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating angiogenic profiles and histo-morphological placental characteristics of uncomplicated post-date pregnancies.
    Mitlid-Mork B; Turowski G; Bowe S; Staff AC; Sugulle M
    Placenta; 2021 Jun; 109():55-63. PubMed ID: 33990027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Maternal serum PlGF associates with 3D power doppler ultrasound markers of utero-placental vascular development in the first trimester: the rotterdam periconception cohort.
    de Vos ES; Danser AHJ; Koning AHJ; Willemsen SP; van der Meeren LE; Steegers EAP; Steegers-Theunissen RPM; Mulders AGMGJ
    Angiogenesis; 2024 Aug; ():. PubMed ID: 39143350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
    Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
    J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Individual risk assessment for prenatal counseling in early-onset growth-restricted and small-for-gestational-age fetuses.
    Mendoza M; Hurtado I; Bonacina E; Garcia-Manau P; Serrano B; Tur H; Rodo C; Maiz N; Carreras E
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):504-512. PubMed ID: 33098097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
    Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine.
    Li SW; Ling Y; Jin S; Lin YF; Chen ZJ; Hu CX; Wang MH; Yao MZ
    Asian Pac J Trop Med; 2014 Aug; 7(8):663-667. PubMed ID: 25149383
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study.
    Barjaktarovic M; Korevaar TIM; Jaddoe VWV; de Rijke YB; Peeters RP; Steegers EAP
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):477-483. PubMed ID: 30834627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
    Aggarwal PK; Chandel N; Jain V; Jha V
    J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Copeptin and mid-regional pro-atrial natriuretic peptide in women with suspected or confirmed pre-eclampsia: comparison with sFlt-1/PlGF ratio.
    Neuman RI; van der Meer MMA; Saleh L; van den Berg SAA; van den Meiracker AH; Danser AHJ; Visser W
    Ultrasound Obstet Gynecol; 2020 Dec; 56(6):872-878. PubMed ID: 31975510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The soluble fms-like tyrosin kinase-1 (sFLT-1) to placental growth factor (PIGF) ratio as a possible indicator for the severity of preeclampsia - single institution experience.
    Müller A; Horvat V; Vulin M; Mandić S; Šerić V; Vidosavljević D
    Med Glas (Zenica); 2019 Feb; 16(1):53-59. PubMed ID: 30680983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease.
    Tongprasert F; Srisupundit K; Luewan S; Tongsong T
    Prenat Diagn; 2013 Dec; 33(13):1272-5. PubMed ID: 24122800
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia.
    Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO
    BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maternal serum sFlt-1/PlGF ratio in twin pregnancies with and without pre-eclampsia in comparison with singleton pregnancies.
    Dröge L; Herraìz I; Zeisler H; Schlembach D; Stepan H; Küssel L; Henrich W; Galindo A; Verlohren S
    Ultrasound Obstet Gynecol; 2015 Mar; 45(3):286-93. PubMed ID: 25491901
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationships of serum placental growth factor and soluble fms-like tyrosine kinase-1 with fetal and uterine artery Doppler indices in pre-eclampsia.
    Li J; Cai A; Yuan Q; Ding H; Zhao D
    Int J Gynaecol Obstet; 2019 May; 145(2):176-181. PubMed ID: 30801711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of ophthalmic artery Doppler with PlGF and sFlt-1/PlGF ratio at 35-37 weeks' gestation in prediction of imminent pre-eclampsia.
    Lau K; Wright A; Sarno M; Kametas NA; Nicolaides KH
    Ultrasound Obstet Gynecol; 2022 May; 59(5):606-612. PubMed ID: 35132725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing the sensitivity of placental growth factor and soluble fms-like tyrosine kinase 1 at 36 weeks' gestation to predict small-for-gestational-age infants or late-onset preeclampsia: a prospective nested case-control study.
    MacDonald TM; Tran C; Kaitu'u-Lino TJ; Brennecke SP; Hiscock RJ; Hui L; Dane KM; Middleton AL; Cannon P; Walker SP; Tong S
    BMC Pregnancy Childbirth; 2018 Aug; 18(1):354. PubMed ID: 30170567
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
    Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
    BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.